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Abstract 
Hyperkalemia affects the myocardial tissue
producing electrocardiographic abnormalities,
such as prolongation of the P-R interval, tall
peaked T waves, a reduction in the amplitude
and an increase in the duration of P wave, and
atrial and ventricular arrhythmias, including
variable degree heart blocks.  Elderly patients
are  particularly  predisposed  to  developing
hyperkalemia and the associated abnormali-
ties  due  to  an  age-related  reduction  in
glomerular  filtration  rate  and  pre-existing
medical  problems.  Therefore,  the  impact  of
aging  on  potassium  homeostasis  must  be
taken  into  consideration,  and  preventive
measures, such as early recognition of possi-
ble hyperkalemia in the geriatric population
treated  with  certain  medications  or  supple-
ments must be investigated. The threshold for
cardiac  arrhythmias  in  the  elderly  can  be
lower than the general population. We report 3
unusual cases of mild hyperkalemia in elderly
patients presenting with hypotension, syncope
and  variable  degree  heart  blocks  which
resolved spontaneously with the correction of
hyperkalemia.
Introduction
Hyperkalemia affects the myocardial tissue
producing electrocardiographic abnormalities,
such  as  prolongation  of  P-R  interval,  tall
peaked T waves, a reduction in the amplitude
and an increase in the duration of P wave, and
atrial and ventricular arrhythmias, including
variable degree heart blocks.1,2
Case Report #1
A 97-year-old female presented to the emer-
gency  department  complaining  of  dizziness
and  syncope.  The  syncope  occurred  at  rest,
without incontinence, tongue bite or residual
neurological deficit. It was not precipitated by
chest pain, difficulty in breathing or any other
symptoms.  The  patient’s  medical  history
included diabetes mellitus, hypertension and
asthma.  On  initial  examination,  her  blood
pressure  was  100/62  mm/Hg,  heart  rate  56
beats-per-minute and regular with no ortho-
static changes in vital signs. Cardiovascular
examination revealed normal first and second
heart sounds with grade 2 systolic murmur in
the mitral and pulmonary auscultation areas.
Other parameters were unremarkable. Home
medications  include:  valsartan,  metformin,
aspirin  and  amlodipine.  Laboratory  findings
included hemoglobin 13.1 g/dL, troponin 0.029,
urea nitrogen 19 mg/dL, creatinine 1.6 mg/dL,
potassium 6.3 mEq/L, sodium 128 mEq/L, chlo-
ride  97  mM/L,  glucose  262  mg/dL.
Echocardiogram  (ECG)  showed  sinus  arrest
and ventricular escape rhythm at a rate of 30
beats  per  minute  with  left  axis  deviation
(Figure 1A). 
The patient was initially treated with intra-
venous  calcium  chloride,  and  intravenous
infusion of normal saline, insulin and glucose.
Serum potassium subsequently decreased to
3.8 mEq/L within a 24 h period and the ECG
showed normal sinus rhythm at a rate of 68
with  no  signs  of  heart  block  (Figure  1B).
Altered atrioventricular conduction was attrib-
uted  to  the  presence  of  mild  hyperkalemia
with decreased creatinine clearance and this
was most likely the cause of the syncope. The
resolution of the hyperkalemia was achieved
after withdrawal of valsartan therapy suggest-
ing that this drug was responsible for the elec-
trolyte  disturbance  in  conjunction  with  dia-
betes  and  an  age-related  reduction  in
glomerular filtration rate (GFR).
Case Report #2
An 86-year old female with medical history
significant for hypertension, asthma and atri-
al fibrillation was brought to the emergency
department  by  her  family  after  they  had
noticed changes in her mental status. She was
found  to  have  bradycardia  and  hypotension.
Initial blood pressure was 70/46 mmHg, and
heart  rate  30  beats-per-minute.  On  physical
examination, the patient was diaphoretic and
in  mild  respiratory  distress.  Cardiovascular
examination  revealed  normal  heart  sounds
with  no  murmurs,  lung  sounds  were  clear
bilaterally, and mucosa membranes were dry.
Laboratory findings were significant for hemo-
globin 11.4 g/dL, troponin 0.035 ng/mL, urea
nitrogen  67  mg/dL,  creatinine  2.2  mg/dL,
potassium 5.7 mEq/L, sodium 137 mEq/L, chlo-
ride  101  mM/L,  glucose  170  mg/dL.  ECG
revealed third degree heart block at a rate of
34 beats per minute. 
The patient was given 1 mg of atropine and
2 L of normal saline followed by transvenous
pacemaker due to refractory hypotension with
bradycardia.  Her  treatment  also  included
insulin with dextrose and continuous admin-
istration  of  normal  saline  for  presumptive
dehydration. Potassium levels normalized to
4.2  over  the  next  two  days  and  no  further
heart  block  was  observed.  Dehydration  and
acute renal failure were determined to be the
cause  of  the  patient’s  hyperkalemia.  The
patient’s family was advised to monitor her
volume status and oral intake of food contain-
ing potassium. 
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Case Report #3
A 70-year old male with significant medical
history of diabetes, hypertension and atrial fib-
rillation was admitted to the hospital for diffi-
culties  in  breathing  and  weakness.  The
patient’s medications were: valsartan, spirono-
lactone, carvedilol and insulin. Blood pressure
on presentation was 86/50 mmHg, heart rate
38  beats-per-minute,  respiration  24  times  a
minute, and temperature 96.4° F. On physical
examination, he was in mild respiratory dis-
tress.  Cardiovascular  examination  revealed
normal heart sounds, bibasilar crackles, and
(+1)  pitting  edema.  Laboratory  findings
included: hemoglobin 10.8 g/dL, troponin 0.020
ng/mL, urea nitrogen 47 mg/dL, creatinine 2.1
mg/dL,  potassium  6.1  mEq/L,  sodium  136
mEq/L, chloride 105 mM/L, glucose 226 mg/dL.
ECG  revealed  sinus  arrest  with  high-grade
heart  block  and  a  junctional  escape  rhythm
(Figure 2A). 
The patient was treated with calcium chlo-
ride 1 gm i.v., insulin 10 units i.v. and dextrose
50 mL of 50% solution. Consequently, serum
potassium normalized to 4.0 mEq/L within 24
h, and follow-up ECG revealed normal sinus
rhythm (Figure 2B) with no signs of a heart
block. Complete heart block was attributed to
the presence of mild hyperkalemia caused by
the patient’s medication in the setting of renal
insufficiency and was most likely the cause of
the patient’s symptoms.
Discussion
Early in the 19th century, prior to the intro-
duction  of  more  acceptable  antiarrhythmics,
potassium salts were used clinically to treat
atrial  and  ventricular  arrhythmias.  It  was
hypothesized that such an alteration could ter-
minate an arrhythmia by suppressing ectopic
foci.3,4However, the use of this agent fell out of
favor,  as  potassium  on  its  own  can  provoke
arrhythmia and heart blocks.5-7 It is worth not-
ing  that  the  occurrence  of  hyperkalemia  in
hospitalized  patients  is  close  to  8%  and
untreated  hyperkalemia-associated  mortality
can  reach  up  to  67%.8-10 Acute  renal  failure
complicates about 5% of hospital admissions
but this percentage is much higher in elderly
patients  and  probably  contributes  to  renal
hypoperfusion  (prerenal  azotemia)  which  is
rapidly  reversible  upon  restoration  of  renal
blood flow.
Elderly patients are principally predisposed
to developing hyperkalemia due to age-related
decline in their renal function, environmental
challenges  leading  to  volume  depletion,  the
presence of diabetes mellitus, cardiovascular
diseases, obstructive nephropathy, the use of
certain medications and overzealous potassi-
um  diets7,11 (Table  1).  Drug  induced  hyper-
kalemia is of clinical importance as the con-
cept of polypharmacy is more common in the
geriatric population because of the presence of
multiple  co-morbidities.  Usually  causes  of
hyperkalemia  can  be  identified  by  taking  a
careful  detailed  history  and  evaluating  rele-
vant laboratory findings. It is not uncommon to
see a geriatric patient with a heart block or a
presentation of syncope due to the presence of
multiple medical problems and lower tolerance
for  electrolyte  disturbances.  However,  it  is
imperative to make an attempt to correct the
underlying disorder causing electrolyte imbal-
ance prior to making a decision which could
subject the patient to a more invasive workup.
Most of the total body potassium is present in
the intracellular space and is estimated to be
close to 98%, with the rest of the potassium
found  in  the  extracellular  space.14,15 Under
normal circumstances, almost 90% of potassi-
um is eliminated by renal excretion and the
rest  by  the  colon.  Nevertheless,  age-related
decline  in  eGFR  impairs  renal  potassium
excretion which is mainly associated with loss
Table 1. Causes of hyperkalemia in the elderly.
Drugs Potassium sparing diuretics (spironolactone, eplerenone, triamterene, 
amiloride), NSAIDs, ACE inhibitors, ARBs, beta blockers, heparin, digoxin 
intoxication, trimethoprim, succinylcholine
Pseudohyperkalemia Leukocytosis, thrombocytosis, hemolysis, rheumatoid arthritis, 
mononucleosis.12,13
Renal failure Acute or chronic (dehydration, obstructive nephropathy, ATN, etc.).
Mineralocorticoid deficiency Addison’s disease, hyporeninemic hypoaldosteronism.
Tissue necrosis Crush injury, tumor lysis, burns.
Metabolic derangement  Acidosis, insulin deficiency.
Potassium intake Supplements, e.g. Kdur, food (orange, banana, mango, etc.), salt 
substitutes, enteral nutritions (Ensure®, pulmocare, glucerna), 
blood  transfusions
Figure 1 (A) 97-year-old female with Syncope, initial ECG. (B) A 97-year old female with
syncope: heart block resolved within 24 h.Case Report
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of nephron mass, as the process involves renal
tubular secretion.7,16 The number of collecting
ducts is directly related to the eGFR and renal
potassium  excretion.  Therefore,  geriatric
patients are more prone to electrolyte distur-
bances causing abnormal conduction through
the heart tissue.7
The  presence  of  hyperkalemia  causes  a
reduction  in  the  resting  transmembrane
potential, a decrease in the rate of rise of the
action potential, and a decrease in myocardial
cell conduction velocity, with an increase in
the rate of repolarization.7,11,17 As the action
potential shortens with increasing potassium
levels and the conduction velocity decreases,
the PR-interval is prolonged, the P-wave ulti-
mately  disappears,  T-waves  become  peaked,
QRS widens and R-R intervals become irregu-
lar.  Consequently,  electrocardiographic  find-
ings include the changes in the underlining
atrioventricular  junctional  rhythm  accompa-
nied by acceleration of junctional pacemaker,
leading  to  conduction  delays  in  the  His-
Purkinje  system  with  generation  of  heart
blocks.18 A rapid increase in potassium levels
can lead to bradycardia and depression of con-
tractile  force,  and  could  be  associated  with
ventricular fibrillation. On the other hand, a
slow  increase  in  potassium  levels  are  more
likely  to  cause  conduction  prolongation  fol-
lowed by asystole, as reported by Ettinger in
1974.18 In one study of 26 patients with mild to
moderate  hyperkalemia,  81%  presented  with
third  degree  heart  block,  with  50%  of  these
patients  requiring  temporary  pacing.19
Prevention of hyperkalemia can be achieved by
adjusting the medication regimen and taking
into consideration reduced renal function. For
example, potassium sparing diuretics can lead
to dehydration and volume depletion, in addi-
tion to impairment of potassium secretion, and
should be used with caution in patients with a
history  of  diabetes  or  urinary  tract  obstruc-
tion.20 Use of non-steroidal anti-inflammatory
drugs (NSAIDs) should be avoided in geriatric
patients with renal insufficiency, heart failure
or liver cirrhosis as it can exacerbate pre-exist-
ing  condition  and  electrolyte  balance.  ACE
inhibitors and beta blockers are commonly pre-
scribed  for  the  treatment  of  hypertension.
Therefore,  any  dose  increase  must  be  man-
aged  with  caution  as  hyperkalemia  can
occur16,21 (Table  2).  Management  of  hyper-
kalemia includes stabilizing the myocardium
to prevent deadly arrhythmias and shifting of
potassium  into  the  cells.32,33 Calcium  glu-
conate 10% solution or calcium chloride can
rapidly  antagonize  the  toxic  effect  of  hyper-
kalemia by lowering the threshold potential,
and its onset of action is usually within a few
minutes.33 Reducing  plasma  potassium  con-
centrations by increasing intracellular move-
ment of potassium can be achieved by using
regular  insulin  10  units  with  dextrose  50%
solution intravenously. Also, beta agonist such
as albuterol 10-20 mg when administered by a
nebulizer can decrease potassium within two
hours  by  cellular  potassium  uptake.16,34
Sodium polystyrene 30-60 gm binds to potassi-
um  in  the  colon  and  can  prevent  further
absorption  of  potassium;  hence,  removing
excess potassium.7 Intravenous hydration with
the use of loop diuretics is also an efficient
way  of  removing  potassium  from  the  body.
Sodium  bicarbonate  therapy  is  controversial
and should be reserved for patients with acade-
mia.35-37 In  patients  presenting  with  severe
hyperkalemia  and  decreased  renal  function,
hemodialysis  should  be  considered  as  this
would  be  the  fastest  way  to  correct  hyper-
kalemia.38 In  geriatric  patients  presenting
with renal failure and hyperkalemia, urinary
tract  obstruction  investigation  should  be
included  in  the  initial  workup  and  a  high
emphasis should be placed on the evaluation of
the medications which can disrupt potassium
balance in the context of the clinical picture
Table 2. Mechanism of action for drug-induced hyperkalemia.
Spironolactone,  Aldosterone antagonist by binding to cytoplasmic aldosterone 
eplerenone receptors,16,22inhibits potassium secretion and sodium reabsorption.
Triamterine/amiloride Blocks Na channels in principal cells.
NSAIDs Reduce renal blood flow, inhibit renal prostaglandin synthesis,23
decrease renal blood perfusion.
Beta blockers Suppress catecholamine stimulated rennin release, decrease 
aldosterone levels and impair cellular uptake of potassium.24,25
Angiotensin converting  Decrease renal blood perfusion, decreases GFR, aldosterone.26
enzyme inhibitors
Heparin Inhibits adrenal aldosterone production.27
Trimethoprim  Blocks potassium secretion by blocking Na channels in principal cells.28,29
(component of bactrim)
Digoxin intoxication Disrupts Na K ATPase transporter, prevents intracellular potassium uptake.30,31
Figure 2. (A) 70-year old male with complete heart block. (B) A 70-year old male after res-
olution of heart block following treatment.Case Report
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and pre-existing medical problems such as dia-
betes,  chronic  kidney  disease,  hypertension,
hypoaldosteronism  and  excessive  potassium
intake.
Conclusions
In our patients, mild hyperkalemia second-
ary to the use of ACE inhibitor and dehydra-
tion, generated depression of the excitability
and conduction velocity of the pacemaker cells
causing variable degree heart blocks, hypoten-
sion and cardiogenic syncope. Elderly patients
should be monitored closely as hyperkalemia
and  reduced  renal  function  can  predispose
them to complete heart blocks, cardiac syncope
and  sudden  cardiac  death.11,18 Consequently,
physicians should be more vigilant even in the
case of a mild rise of potassium in the geriatric
population presenting with heart blocks since
sinus  rhythm  can  be  appropriately  restored
without subjecting the patient to further inva-
sive workup.
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